EcoDrugPlus

Elastase, Neutrophil Expressed

Ensembl ID : ENSBTAG00000046188
Gene Symbol: ELANE
12 Enzyme and pathways 5 Cross references
103 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSBTAG00000003711
Gene Symbol: EPAS1
8 Enzyme and pathways 5 Cross references
236 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSBTAG00000002977
Gene Symbol: ECE1
5 Enzyme and pathways 5 Cross references
242 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSBTAG00000013674
Gene Symbol: EDNRA
7 Enzyme and pathways 5 Cross references
282 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSBTAG00000005299
Gene Symbol: EDNRB
7 Enzyme and pathways 5 Cross references
279 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSBTAG00000009426
Gene Symbol: EZH2
18 Enzyme and pathways 5 Cross references
247 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSBTAG00000011628
Gene Symbol: EGFR
30 Enzyme and pathways 5 Cross references
300 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSBTAG00000015241
Gene Symbol: EPHX2
10 Enzyme and pathways 5 Cross references
216 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSBTAG00000021798
Gene Symbol: ERBB2
27 Enzyme and pathways 5 Cross references
212 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSBTAG00000010444
Gene Symbol: ERBB3
20 Enzyme and pathways 5 Cross references
292 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSBTAG00000012647
Gene Symbol: ERBB4
26 Enzyme and pathways 5 Cross references
332 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSBTAG00000007159
Gene Symbol: ESR1
27 Enzyme and pathways 5 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).